189 related articles for article (PubMed ID: 22449513)
1. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study.
Coelho LM; Salluh JI; Soares M; Bozza FA; Verdeal JC; Castro-Faria-Neto HC; Lapa e Silva JR; Bozza PT; Póvoa P
Crit Care; 2012 Dec; 16(2):R53. PubMed ID: 22449513
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study.
Póvoa P; Teixeira-Pinto AM; Carneiro AH;
Crit Care; 2011 Jul; 15(4):R169. PubMed ID: 21762483
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course.
Coelho L; Póvoa P; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H
Crit Care; 2007; 11(4):R92. PubMed ID: 17723153
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and albumin kinetics after antibiotic therapy in community-acquired bloodstream infection.
Póvoa P; Garvik OS; Vinholt PJ; Pedersen C; Jensen TG; Kolmos HJ; Lassen AT; Gradel KO
Int J Infect Dis; 2020 Jun; 95():50-58. PubMed ID: 32251802
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study.
Póvoa P; Coelho L; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H
Eur Respir J; 2005 May; 25(5):804-12. PubMed ID: 15863636
[TBL] [Abstract][Full Text] [Related]
6. Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer.
Rabello LSCF; Póvoa P; Lapa E Silva JR; Azevedo LCP; da Silva Ramos FJ; Lisboa T; Soares M; Salluh JIF
J Crit Care; 2017 Dec; 42():231-237. PubMed ID: 28797895
[TBL] [Abstract][Full Text] [Related]
7. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.
Martin-Loeches I; Lisboa T; Rodriguez A; Putensen C; Annane D; Garnacho-Montero J; Restrepo MI; Rello J
Intensive Care Med; 2010 Apr; 36(4):612-20. PubMed ID: 19953222
[TBL] [Abstract][Full Text] [Related]
8. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.
Ito A; Ito I; Inoue D; Marumo S; Ueda T; Nakagawa H; Taki M; Nakagawa A; Tatsumi S; Nishimura T; Shiota T; Ishida T
Int J Infect Dis; 2020 Mar; 92():228-233. PubMed ID: 31981766
[TBL] [Abstract][Full Text] [Related]
9. Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management.
Que YA; Virgini V; Lozeron ED; Paratte G; Prod'hom G; Revelly JP; Pagani JL; Charbonney E; Eggimann P
Infection; 2015 Apr; 43(2):193-9. PubMed ID: 25732200
[TBL] [Abstract][Full Text] [Related]
10. Patterns of C-reactive protein ratio response to antibiotics in pediatric sepsis: A prospective cohort study.
Lanziotti VS; Póvoa P; Prata-Barbosa A; Pulcheri LB; Rabello LSCF; Lapa E Silva JR; Soares M; Salluh JIF
J Crit Care; 2018 Apr; 44():217-222. PubMed ID: 29161668
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.
Marrie TJ; Shariatzadeh MR
Medicine (Baltimore); 2007 Mar; 86(2):103-111. PubMed ID: 17435590
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.
Bruns AH; Oosterheert JJ; Hak E; Hoepelman AI
Eur Respir J; 2008 Sep; 32(3):726-32. PubMed ID: 18508833
[TBL] [Abstract][Full Text] [Related]
13. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia.
Sohn CH; Ryoo SM; Yoon JY; Seo DW; Lim KS; Kim SH; Hong SB; Lim CM; Koh YS; Kim WY
Acad Emerg Med; 2013 Jan; 20(1):46-53. PubMed ID: 23570478
[TBL] [Abstract][Full Text] [Related]
15. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
16. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study.
Póvoa P; Coelho L; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H
Crit Care; 2006; 10(2):R63. PubMed ID: 16635270
[TBL] [Abstract][Full Text] [Related]
17. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
Yu Z; Ji M; Hu X; Yan J; Jin Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
[TBL] [Abstract][Full Text] [Related]
18. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
[TBL] [Abstract][Full Text] [Related]
19. Plasma kallistatin levels in patients with severe community-acquired pneumonia.
Lin WC; Lu SL; Lin CF; Chen CW; Chao L; Chao J; Lin YS
Crit Care; 2013 Feb; 17(1):R27. PubMed ID: 23394256
[TBL] [Abstract][Full Text] [Related]
20. Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.
Salluh JIF; Bozza FA; Soares M; Verdeal JCR; Castro-Faria-Neto HC; Lapa E Silva JR; Bozza PT
Chest; 2008 Nov; 134(5):947-954. PubMed ID: 18753464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
